Ledger.Open graph →
SEC Form D · filed July 30, 2020

Gain Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BETHESDA, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Khalid I. Islam · Bethesda, MDDirectorMarianne I. Bjordal · Bethesda, MDDirectorJeffrey I. Riley · Bethesda, MDDirectorLorenzo I. Leoni · Bethesda, MDDirectorEric I. Richman · Annapolis, MDExec · DirectorKhalid I. Islam · Bethesda, MDDirectorMarianne I. Bjordal · Bethesda, MDDirectorJeffrey I. Riley · Bethesda, MDDirectorLorenzo I. Leoni · Bethesda, MDDirectorEric I. Richman · Bethesda, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗